期刊文献+

分析高脂血症患者长期口服二甲双胍联合瑞舒伐他汀治疗的临床疗效及安全性

To analyze the clinical efficacy and safety of long-term oral metformin combined with rosuvastatin in patients with hyperlipidemia
下载PDF
导出
摘要 目的分析二甲双胍联合瑞舒伐他汀长期口服治疗高脂血症的临床疗效及安全性。方法将2016年5月-12月某院收治的73例高脂血症患者作为实验组,予以二甲双胍联合瑞舒伐他汀治疗,同期遵循1∶1配对原则将另73例高脂血症患者作为对照组,予以二甲双胍治疗,两组均在用药第3、6、12个月时观察疗效,并对药物长期口服的安全性进行对比分析。结果两组患者治疗第3、6、12个月后的血脂指标较治疗前明显改善(P<0.05);实验组治疗后各时间段的治疗总有效率明显高于对照组(P<0.05)。两组患者各时间段复查尿常规、肝肾功能等各项指标,未见严重的不良反应事件(P>0.05);治疗期间有个别患者出现胃肠副反应、乏力、瘙痒等,但均为短暂性或轻度,两组间无统计学差异(P>0.05)。结论长期口服二甲双胍与瑞舒伐他汀治疗高脂血症,临床疗效显著,安全性高,属于比较合理的用药方案。 Objective To analyze the clinical efficacy and safety of metformin combined with rosuvastatin for long-term oral treat⁃ment of hyperlipidemia.Methods Seventy-three patients with hyperlipidemia treated in a hospital from May 2016 to December 2016 were treated with metformin combined with rosuvastatin as the experimental group,and another 73 patients with hyperlipidemia were treated with metformin as the control group according to the 1:1 matching principle.The efficacy of the two groups was observed at 3,6 and 12 months of drug administration,and the safety of long-term oral administration of the drug was compared and analyzed.Results The blood lipid index of the two groups after 3,6 and 12 months of treatment was significantly improved compared with that before treatment(P<0.05);the total effective rate of the experimental group was significantly higher than that of the control group at each time period after treatment(P<0.05).There were no serious adverse reactions(P>0.05)in urine routine examination,liver and kidney function and other indicators in both groups during each time period.During the treatment period,there were some gastrointesti⁃nal side effects,fatigue,pruritus in individual patients,but they were transient or mild,and there was no statistical difference between the two groups(P>0.05).Conclusion Long-term oral metformin and rosuvastatin treatment of hyperlipidemia,clinical efficacy is sig⁃nificant,high safety,belongs to a more reasonable drug regimen.
作者 刘现翠 单鹏 Liu Xiancui;Shan Peng(Ji'nan Third People's Hospital,Ji'nan 250132,Shandong,China;Tengzhou Central People's Hospital,Tengzhou 277599,Shandong,China)
出处 《医院与医学》 2020年第2期39-43,共5页 Hospital and Medicine
关键词 高脂血症 二甲双胍 瑞舒伐他汀 安全性 Hyperlipidemia Metformin Rosuvastatin Safety
  • 相关文献

二级参考文献78

  • 1王成章,杨红霞,马丽苹,高义,魏士贤.脂康颗粒治疗老年高脂血症80例临床观察[J].华北国防医药,2006,18(5):341-342. 被引量:3
  • 2牛纪华,王晓萍,徐艳春,席崇,田相同.脂康颗粒治疗高脂血症临床研究[J].山东中医杂志,2007,26(2):103-104. 被引量:9
  • 3中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5224
  • 4Kanaki AI, Sarafidis PA, Georgianos PI, et al. Effects of low-dose atorvastatin on arterial stiffness and central aor- tic pressure augmentation in patients with hypertension and hypercholesterolemia[J]. Am J Hypertens, 2013,26 (5) :608-616. 被引量:1
  • 5Reyes Marin FA,Calzada C, Ballesteros A, et al. Compar- ative study of enalapril vs. losartan on residual renal func- tion preservation in automated peritoneal dialysis. A ran- domized controlled study[J]. Rev Invest Clin, 2012, 64 (4):315-332. 被引量:1
  • 6Jin D, Wu Y, Zhao L, et al. Atorvastatin reduces serum HMGB1 levels in patients with hyperlipidemia[J]. Exp Ther Med,2012,4(6) : 1124-1126. 被引量:1
  • 7Kishi T, Sunagawa K. Combination therapy of atorvasta- tin and amlodipine inhibits sympathetic nervous system activation and improves cognitive function in hypertensive rats[J]. Circ J ,2012,76(8) :1934-1941. 被引量:1
  • 8Matsue Y, Matsumura A, Suzuki M, et al. Differences in action of atorvastatin and ezetimibe in lowering low-den- sity lipoprotein cholesterol and effect on endothelial func- tion[J]. Circ J ,2013,77(7) :1791-1798. 被引量:1
  • 9WANG DW, LIU M, Effect of Rosuvastatin on newly coronary events, plasma lipid and hs-CRP level after coronary stenting[J]. Journal of Zhengzhou University, 2012, 47(1): 72-74. Chinese. 被引量:1
  • 10LIU B, CHE W, YAN H, et al. Effects of Rosuvastatin vs simvastatin/ezetimibe on arterial wall stiffness in patients with coronary artery disease[J]. Intern Med, 2013, 52(24): 2715-2719. 被引量:1

共引文献120

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部